
Abfero Pharmaceuticals
Innovative oral iron chelators targeting diseases of iron overload with a focus on neurodegenerative and retinal disorders.
Employees
Enterprise value
$225m
Authorizing premium user...
Innovative oral iron chelators targeting diseases of iron overload with a focus on neurodegenerative and retinal disorders.